← Back to directory

Martin Pichler

Researcher Next ID · RN-040058

Researcher · Biochemistry, Genetics and Molecular Biology

University of Augsburg

Augsburg, Austria

Accepting doctoral researchersFunding unknown
Works count
572
Citation count
17,069
H-index
70
i10-index
269

Research interests

Biochemistry, Genetics and Molecular Biology
Medicine
Cancer-related molecular mechanisms research
Renal cell carcinoma treatment
Inflammatory Biomarkers in Disease Prognosis
MicroRNA in disease regulation
Cancer Genomics and Diagnostics

Publications

  • Non-coding RNAs and ferroptosis: potential implications for cancer therapy

    Cell Death and Differentiation · 2022 · 10.1038/s41418-022-00998-x

  • RNA-Binding Proteins as Important Regulators of Long Non-Coding RNAs in Cancer

    International Journal of Molecular Sciences · 2020 · 10.3390/ijms21082969

  • Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study

    Journal of Clinical Oncology · 2019 · https://doi.org/10.1200/jco.18.01480

  • Involvement of the long noncoding RNA NEAT 1 in carcinogenesis

    Molecular Oncology · 2018 · 10.1002/1878-0261.12404

  • Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer

    OncoImmunology · 2017 · 10.1080/2162402x.2017.1378844

  • MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase

    Oncotarget · 2016 · 10.18632/oncotarget.14264

  • Whole-genome plasma sequencing reveals focal amplifications as a driving force in metastatic prostate cancer

    Nature Communications · 2016 · 10.1038/ncomms12008

  • Ubiquitous Release of Exosomal Tumor Suppressor miR-6126 from Ovarian Cancer Cells

    Cancer Research · 2016 · 10.1158/0008-5472.can-16-0714

  • MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients

    British Journal of Cancer · 2015 · 10.1038/bjc.2015.253

  • Junk DNA and the long non-coding RNA twist in cancer genetics

    Oncogene · 2015 · https://doi.org/10.1038/onc.2014.456

  • The Preoperative AST/ALT (De Ritis) Ratio Represents a Poor Prognostic Factor in a Cohort of Patients with Nonmetastatic Renal Cell Carcinoma

    The Journal of Urology · 2015 · 10.1016/j.juro.2015.01.083

  • Tumor Macroenvironment and Metabolism

    Seminars in Oncology · 2014 · 10.1053/j.seminoncol.2014.02.005

  • Changes in Colorectal Carcinoma Genomes under Anti-EGFR Therapy Identified by Whole-Genome Plasma DNA Sequencing

    PLoS Genetics · 2014 · 10.1371/journal.pgen.1004271

  • Validation of the pre-treatment neutrophil–lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients

    British Journal of Cancer · 2013 · 10.1038/bjc.2013.28

  • Platelet-to-Lymphocyte Ratio: A Novel Marker for Critical Limb Ischemia in Peripheral Arterial Occlusive Disease Patients

    PLoS ONE · 2013 · 10.1371/journal.pone.0067688

  • Establishment of tumor‐specific copy number alterations from plasma DNA of patients with cancer

    International Journal of Cancer · 2013 · 10.1002/ijc.28030

  • The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer

    British Journal of Cancer · 2013 · 10.1038/bjc.2013.785

  • The lymphocyte/monocyte ratio predicts poor clinical outcome and improves the predictive accuracy in patients with soft tissue sarcomas

    International Journal of Cancer · 2013 · 10.1002/ijc.28677

  • Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing

    Genome Medicine · 2013 · 10.1186/gm434

  • Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer

    British Journal of Cancer · 2013 · 10.1038/bjc.2013.332

  • A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients

    British Journal of Cancer · 2013 · 10.1038/bjc.2013.346

  • Validation of C-reactive protein levels as a prognostic indicator for survival in a large cohort of pancreatic cancer patients

    British Journal of Cancer · 2013 · 10.1038/bjc.2013.701

  • Complex Tumor Genomes Inferred from Single Circulating Tumor Cells by Array-CGH and Next-Generation Sequencing

    Cancer Research · 2013 · 10.1158/0008-5472.can-12-4140

  • Heterogeneity of Epidermal Growth Factor Receptor Status and Mutations of KRAS/PIK3CA in Circulating Tumor Cells of Patients with Colorectal Cancer

    Clinical Chemistry · 2012 · 10.1373/clinchem.2012.188557

Current projects

    No projects listed.